Pages
Patient Group Directions (PGDs)
Patient Group Directions - PGDs provide a legal framework that allows some registered health professionals to supply and/or administer a specified medicine(s) to a pre-defined group of patients, without them having to see a prescriber.
Files
Disclosure Ref 2024215 - Patient Communication & e-consent systems.pdf
Freedom of information disclosure regarding disclosure Ref 2024215 - Patient Communication & e-consent systems
Disclosure Ref 202574 - Procurement process for Patient Transport Service contracts .pdf
Freedom of information disclosure ref 2025/75 relating to the outline of the procurement process for Patient Transport Service contracts
Disclosure Ref 2025162 - Parathyroidectomies .pdf
FOI Disclosure Ref 2025162 relating to number of Parathyroidectomies were undertaken in 2023
Disclosure Ref 2025140 - Patient Engagement Portal.pdf
FOI Disclosure Ref 2025140 regarding Patient Engagement Portal (also known as a Patient Portal)
Disclosure Ref 2025197 - Patients admitted to A&E for treatment as a result of cycling and pothole injuries.pdf
Freedom of information disclosure reference 2025197 relating to patients admitted to A&E for treatment as a result of cycling and pothole injuries
Disclosure Ref 2025179 - Systems used and storing data.pdf
Freedom of Information disclosure reference 2025179 relating to how we scan and digitise records.
Dressing Formulary and Wound Care Guidelines (G68)
The Derbyshire Wound Care and dressing formulary has been revised in collaboration with the East Midlands Wound Care Formulary Group. Work has been undertaken to provide a clinically effective, appropriate and cost effective choices of products to manage the vast majority of wounds. The formulary is available for all practitioners working for Derbyshire Community Health Services and Primary Care Services. It is expected that prescribers will preferentially use the products listed in the guide for routine use and be able to provide robust rationale where they have prescribed outside the formulary.
Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)
The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.
Ward-Decoration-Guidelines.docx
Christmas 2021 - IP&C guidance
DCHS Community Podiatry eligibility leaflet (2020).pdf
DCHS Community Podiatry eligibility leaflet (2020)